Medpace Holdings Inc (NASDAQ: MEDP) has seen a rise in its stock price by 2.24 in relation to its previous close of 346.81. However, the company has experienced a 6.73% gain in its stock price over the last five trading sessions. accesswire.com reported 2025-01-08 that LOS ANGELES, CA / ACCESSWIRE / January 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Is It Worth Investing in Medpace Holdings Inc (NASDAQ: MEDP) Right Now?
The price-to-earnings ratio for Medpace Holdings Inc (NASDAQ: MEDP) is above average at 31.05x, Company’s 36-month beta value is 1.36.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for MEDP is 25.49M, and currently, short sellers hold a 4.57% ratio of that floaft. The average trading volume of MEDP on January 09, 2025 was 327.43K shares.
MEDP’s Market Performance
MEDP’s stock has seen a 6.73% increase for the week, with a 1.16% rise in the past month and a 4.86% gain in the past quarter. The volatility ratio for the week is 2.89%, and the volatility levels for the past 30 days are at 2.80% for Medpace Holdings Inc The simple moving average for the past 20 days is 3.87% for MEDP’s stock, with a -4.55% simple moving average for the past 200 days.
Analysts’ Opinion of MEDP
Many brokerage firms have already submitted their reports for MEDP stocks, with Robert W. Baird repeating the rating for MEDP by listing it as a “Neutral.” The predicted price for MEDP in the upcoming period, according to Robert W. Baird is $349 based on the research report published on October 23, 2024 of the previous year 2024.
UBS gave a rating of “Neutral” to MEDP, setting the target price at $350 in the report published on September 27th of the previous year.
MEDP Trading at 4.62% from the 50-Day Moving Average
After a stumble in the market that brought MEDP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.88% of loss for the given period.
Volatility was left at 2.80%, however, over the last 30 days, the volatility rate increased by 2.89%, as shares surge +0.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.38% upper at present.
During the last 5 trading sessions, MEDP rose by +6.73%, which changed the moving average for the period of 200-days by -13.26% in comparison to the 20-day moving average, which settled at $341.37. In addition, Medpace Holdings Inc saw 6.73% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MEDP starting from Kraft Robert O., who sale 4,353 shares at the price of $390.73 back on Aug 22 ’24. After this action, Kraft Robert O. now owns 520 shares of Medpace Holdings Inc, valued at $1,700,848 using the latest closing price.
Kraft Robert O., the Director of Medpace Holdings Inc, sale 3,774 shares at $390.73 during a trade that took place back on Aug 23 ’24, which means that Kraft Robert O. is holding 520 shares at $1,474,615 based on the most recent closing price.
Stock Fundamentals for MEDP
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.29 for the gross margin
The net margin for Medpace Holdings Inc stands at 0.18. The total capital return value is set at 0.39. Equity return is now at value 54.06, with 20.48 for asset returns.
Currently, EBITDA for the company is 363.15 million with net debt to EBITDA at -1.19. When we switch over and look at the enterprise to sales, we see a ratio of 5.07. The receivables turnover for the company is 6.65for trailing twelve months and the total asset turnover is 0.99. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.99.
Conclusion
In a nutshell, Medpace Holdings Inc (MEDP) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
